Inventor · disambiguated record
Mary G. Hoffee
Also filed as: HOFFEE MARY G
7 granted patents·3 pending applications·271 citations·filing 2003–2018
89Inventor score
Top patents by PatentIndex Score
10 records- 0198US7557189B2Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2003·Granted Jul 7, 2009·109 cites·44 claims
- 0298US7342110B2Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2006·Granted Mar 11, 2008·82 cites·10 claims
- 0397US9359442B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2014·Granted Jun 7, 2016·29 cites·10 claims
- 0496US8119787B2Molecular tools for manufacturing anti-CD33 antibodies and fragmentsHOFFEE MARY G·Filed 2009·Granted Feb 21, 2012·21 cites·20 claims
- 0595US8337855B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameHOFFEE MARY G·Filed 2011·Granted Dec 25, 2012·26 cites·17 claims
- 0688US8747851B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2012·Granted Jun 10, 2014·4 cites·7 claims
- 0771US2009291090A1Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2009·Application pending·0 cites
- 0869US2008167458A1Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2007·Application pending·0 cites
- 0969US2018362646A1Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2018·Application pending·0 cites
- 1066US10000566B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2016·Granted Jun 19, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Mary G. Hoffee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →